NewGenIvf Group Limited Class A Ordinary Shares (NASDAQ:NIVF) — Market Cap & Net Worth
Market Cap & Net Worth: NewGenIvf Group Limited Class A Ordinary Shares (NIVF)
NewGenIvf Group Limited Class A Ordinary Shares (NASDAQ:NIVF) has a market capitalization of $765.65K ($765.65K) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30638 globally and #6128 in its home market, demonstrating a -8.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NewGenIvf Group Limited Class A Ordinary Shares's stock price $0.58 by its total outstanding shares 1317135 (1.32 Million). Review NewGenIvf Group Limited Class A Ordinary balance sheet liabilities to assess the company's total debt and financial obligations.
NewGenIvf Group Limited Class A Ordinary Shares Market Cap History: 2024 to 2026
NewGenIvf Group Limited Class A Ordinary Shares's market capitalization history from 2024 to 2026. Data shows change from $549.64K to $765.65K (-71.28% CAGR).
Index Memberships
NewGenIvf Group Limited Class A Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.00% | #909 of 976 |
Weight: NewGenIvf Group Limited Class A Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NewGenIvf Group Limited Class A Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NewGenIvf Group Limited Class A Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.10x
NewGenIvf Group Limited Class A Ordinary Shares's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $549.64K | $5.43 Million | -$525.00K | 0.10x | N/A |
Competitor Companies of NIVF by Market Capitalization
Companies near NewGenIvf Group Limited Class A Ordinary Shares in the global market cap rankings as of June 17, 2026.
Key companies related to NewGenIvf Group Limited Class A Ordinary Shares by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #329 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #999 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.58 Billion USD ( €21.88 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1344 globally with a market cap of $19.28 Billion USD ( RM76.79 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #329 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $389.97 |
| #999 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.58 Billion | €38.85 |
| #1344 | IHH Healthcare Bhd | KLSE:5225 | $19.28 Billion | RM8.69 |
NewGenIvf Group Limited Class A Ordinary Shares Historical Marketcap From 2024 to 2026
Between 2024 and today, NewGenIvf Group Limited Class A Ordinary Shares's market cap moved from $549.64K to $ 765.65K, with a yearly change of -71.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $765.65K | -15.75% |
| 2025 | $908.82K | +65.35% |
| 2024 | $549.64K | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of NewGenIvf Group Limited Class A Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $765.65K USD |
| MoneyControl | $765.65K USD |
| MarketWatch | $765.65K USD |
| marketcap.company | $765.65K USD |
| Reuters | $765.65K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sp… Read more